eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2003
vol. 28
 
Share:
Share:
abstract:

Anti-inflammatory drugs in asthma therapy

Andrzej Obojski
,
Maria Kraus-Filarska

(Centr Eur J Immunol 2003; 28 (1): 29–35)
Online publish date: 2004/01/20
View full text Get citation
 
Abstract
Asthma is a chronic inflammatory disease. Pharmacologic management of asthma comprises long-term treatment to suppress the airway inflammation and quick-relief treatment to provide prompt reversal of acute bronchoconstriction and its accompanying symptoms. Anti-inflammatory agents are of crucial importance in asthma therapy. The most potent and effective medications used for long-term treatment of asthma are inhaled corticosteroids. Other medications, like: cromones, leukotriene antagonists and theophylline also show, but much less, anti-inflammatory activity. They can be used alternatively to inhaled corticosteroids in patients with mild persistent asthma but they are less effective. The add-on therapy with those medications should be considered if asthma control is not achieved with initial inhaled corticosteroid therapy. The combination treatment with long-acting β2-agonists and inhaled corticosteroids has become the treatment of choice for the majority of asthmatic patients and nowadays constitutes the new ”gold standard” of asthma therapy.
keywords:

anti-inflammatory agents, inhaled corticosteroids, leukotriene antagonists, long-acting β2-agonists, theophylline, cromones

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.